TNON · Tenon Medical, Inc. · Insider Trading

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

These shares were sold to pay tax liability associated with the vesting of RSUs.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026.

Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Resulting in short sales.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

Represents conversion of 58,987 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 64,479 restricted stock units granted to the reporting person on October 13, 2025 into 64,479 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 140,936 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 140,936 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 126,577 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 126,577 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.

Represents conversion of 58,987 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 140,936 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 140,936 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 64,479 restricted stock units granted to the reporting person on October 13, 2025 into 64,479 shares of common stock of the Issuer on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 49.38% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 24.69% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.